Third Generation Sequencing Market Size Was Valued at USD 10.10 Billion in 2023, and is Projected to Reach USD 50.57 Billion by 2032, Growing at a CAGR of 19.60 % From 2024-2032.

Eczema Therapeutics market refers to all the efforts, processes and products that are used to develop, manufacture and distribute products used in the management of Eczema; a skin condition that results in redness, itching and inflammation. The market is more inclined towards the topical therapies including oral medication, biologics and other sophisticated products which intends to provide relief from symptoms by enhancing the health standards of the patients.